Puluo Pharmaceutical Subsidiary Purchases 50 Million RMB Blockchain Receivables

According to Sina Finance, Debang Pharmaceutical, a wholly-owned subsidiary of Prolog Pharmaceuticals, recently used its own funds to purchase 50 million yuan of blockchain receivable products through Zheshang Bank and the bond transfer platform. Confirmed, the expected annualized yield is 4.35%.